Skip to search.
New User?
Register
Sign In
Help
Make Y! My Homepage
Notifications
Help
Mail
My Y!
Yahoo!
Yahoo! Finance
Search
Search Web
Breaking News
Visit Yahoo! News for the latest.
×
Close this window
HOME
INVESTING
Market Overview
Market Stats
Stocks
Mutual Funds
ETFs
Bonds
Options
Industries
Currencies
Education
Commodities
NEWS
Markets
Investing Ideas
Special Editions
Company Finances
RSS Feeds
Video
Photos & Interactives
PERSONAL FINANCE
Career & Education
Insurance
Lifestyle
Loans
Real Estate
Retirement
Saving & Spending
Taxes
Glossary
Your Money 101
MY PORTFOLIOS
Sign in to access My Portfolios
Free trial of Real-Time Quotes
EXCLUSIVES
Breakout
The Daily Ticker
The Exchange
Unexpected Returns
Financially Fit
Just Explain It
Hot Stock Minute
CNBC
Big Data Download
Off the Cuff
Talking Numbers
Latest Headlines
Search for share prices
Search for share prices
Finance Search
Tue, May 21, 2013, 3:09AM EDT - U.S. Markets open in 6 hrs 21 mins
Dow
0.12%
Nasdaq
0.07%
More On ACT
Quotes
Summary
Order Book
Options
Historical Prices
Charts
Interactive
Basic Chart
Basic Tech. Analysis
News & Info
Headlines
Press Releases
Company Events
Message Boards
Market Pulse
Company
Profile
Key Statistics
SEC Filings
Competitors
Industry
Components
Analyst Coverage
Analyst Opinion
Analyst Estimates
Research Reports
Ownership
Major Holders
Insider Transactions
Insider Roster
Financials
Income Statement
Balance Sheet
Cash Flow
Actavis, Inc. (ACT)
-
NYSE
127.15
May 20, 4:00PM EDT
Add to Portfolio
Press Releases
Get Press Releases for:
Monday, May 20, 2013
Actavis to Acquire Warner Chilcott to Create Premier $11 Billion Revenue Global Specialty Pharmaceutical Company
PR Newswire
( (Mon, May 20)
Tuesday, May 14, 2013
Announcement Under Irish Takeover Rules Relevant Securities in Issue
PR Newswire
( (Tue, May 14)
Monday, May 13, 2013
Actavis' NDA for Progestin-Only Patch Accepted for Filing by FDA
PR Newswire
( (Mon, May 13)
Actavis Cancels Presentation at Bank of America Merrill Lynch Healthcare Conference
PR Newswire
( (Mon, May 13)
Friday, May 10, 2013
Actavis Confirms Early Stage Discussions Regarding Potential Combination with Warner Chilcott plc
PR Newswire
( (Fri, May 10)
Thursday, May 9, 2013
Actavis Confirms District Court Ruling In Generic Lialda® Patent Suit
PR Newswire
( (Thu, May 9)
Tuesday, May 7, 2013
Actavis, Inc. to Present at the Bank of America Merrill Lynch 2013 Health Care Conference
PR Newswire
( (Tue, May 7)
Friday, May 3, 2013
Actavis to Host Annual Meeting of Stockholders on May 10, 2013
PR Newswire
( (Fri, May 3)
Thursday, May 2, 2013
Actavis First Quarter 2013 Net Revenue Increases 24% to $1.9 Billion
PR Newswire
( (Thu, May 2)
Wednesday, May 1, 2013
Actavis Acquires Worldwide Rights for Valeant's Metronidazole 1.3% Vaginal Gel
CNW Group
( (Wed, May 1)
Actavis Acquires Worldwide Rights for Valeant's Metronidazole 1.3% Vaginal Gel
PR Newswire
( (Wed, May 1)
Actavis Acquires Worldwide Rights for Valeant's Metronidazole 1.3% Vaginal Gel
PR Newswire
( (Wed, May 1)
95993774